aromasil has been researched along with dinoprostone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Salle, E; Engan, T; Johannessen, DC; Kvinnsland, S; Lonning, PE; Ornati, G; Paolini, J; Piscitelli, G; Zurlo, MG | 1 |
| Du, YY; Hu, LX; Pan, YY; Zhang, Y | 1 |
| Clark, BL; Kamdem, LK; Murphy, MA | 1 |
1 trial(s) available for aromasil and dinoprostone
| Article | Year |
|---|---|
Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.
Topics: Aged; Alprostadil; Androgens; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dinoprostone; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Postmenopause | 1997 |
2 other study(ies) available for aromasil and dinoprostone
| Article | Year |
|---|---|
Synergistic effects of exemestane and aspirin on MCF-7 human breast cancer cells.
Topics: Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Dinoprostone; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Female; Flow Cytometry; Humans; Tumor Cells, Cultured | 2012 |
COX2 induction: a mechanism of endocrine breast cancer resistance?
Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Case-Control Studies; Chromatography, Liquid; Cyclooxygenase 2; Dinoprostone; Drug Monitoring; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Postmenopause; Retrospective Studies; Tandem Mass Spectrometry | 2017 |